Growth & Failure cover image

Dr. Aoife Brennan, President & CEO of Synlogic Therapeutics

Growth & Failure

CHAPTER

Synthetic Biology to Bacterial Diseases

Sinlogic uses synthetic biology to treat metabolic diseases. The company has two programs down the clinic, one for an inherited disease called fenal cetonuria. Another is a acquired metabolic disease where patients have elevated oxilate in leafy green fruits and vegetables or nuts and tea.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner